Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMicro-X Ltd

Micro-X Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.03 AUD 0.00(0%)
Last update at 2026-11-12T01:57:00Z
VOLUME
1197676
Market Cap
25.22M

Momentum Score

…

Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; and imaging chains and custom X-ray imaging solutions, as well as engineering contract services and spare parts. The company has a strategic partnership with Billion Prima to develop and commercialize a baggage and parcel scanner product. Micro-X Limited was incorporated in 2011 and is based in Adelaide, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.03
Low
0.03
High
52 Week Price Range
0.01
Low
0.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Micro-X Ltd develops and commercial systems for lightweight X‑ray imaging using carbon nanotube (CNT) X‑ray source technology for medical, security and industrial applications. Long‑term growth drivers include wider commercial adoption of portable, low‑power imaging, regulatory clearances and scaling manufacturing and sales, and investors may find the company attractive for its differentiated, compact X‑ray approach that could enable new form factors and deployment models.
Primary risks include early‑stage commercialisation, dependence on regulatory approvals and external funding, competition from established imaging suppliers and execution risk in scaling production and sales.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.03
Dividend Yield
-
Revenue TTM
15.09M
Revenue Per Share
0.02
Gross Profit TTM
5.39M
Debt / Equity
1.32
ROE
-157.98%
Net Debt
3.34M
ROCE
-187.86%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -15.55M -13.89M -9.77M -10.75M -17.09M
Net income -9.88M -13.89M -9.77M -10.75M -17.09M
Selling general administrative - 18.04M 17.39M 17.79M 16.67M
Selling and marketing expenses - 0.91M 0.94M 1.38M 0.86M
Gross profit -9.15M 10.32M 5.74M 11.50M 5.00M
Reconciled depreciation - 1.57M 1.54M 1.66M 1.43M
Ebit - -13.33M -15.89M -10.48M -16.79M
Ebitda -15.80M -11.76M -14.35M -8.83M -15.36M
Depreciation and amortization - 1.57M 1.54M 1.66M 1.43M
Operating income -15.80M -17.05M -13.03M -17.88M -20.94M
Other operating expenses 30.88M 30.11M 28.25M -5.59M -8.96M
Interest expense 0.52M 0.56M 0.25M 0.27M 0.30M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.06M 0.04M 0.00M 0.02M
Net interest income - -0.50M -0.21M -0.27M -0.28M
Income tax expense -5.67M - -6.37M 7.66M 4.42M
Total revenue 15.09M 13.05M 15.22M 15.01M 8.97M
Total operating expenses 6.64M 27.37M 18.76M 29.45M 25.94M
Cost of revenue 24.24M 2.73M 9.48M 3.50M 3.97M
Total other income expense net 0.25M 3.16M 3.26M 7.39M 4.12M
Net income from continuing ops - -13.89M -9.77M -10.75M -17.09M
Net income applicable to common shares - -13.89M -9.77M -10.75M -17.09M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 19.72M 22.11M 26.89M 30.30M 31.28M
Intangible assets 0.01M 0.02M - 0.13M 0.14M
Other current assets 0.46M 0.84M 1.14M 1.63M 1.31M
Total liab 14.81M 14.56M 12.70M 13.11M 11.99M
Total stockholder equity 4.91M 7.55M 14.20M 17.19M 19.29M
Deferred long term liab - - - 0.05M 0.06M
Other current liab 5.19M 0.18M 5.14M 4.61M 4.08M
Common stock - - 131.93M 125.40M 117.53M
Capital stock - 138.41M - 125.46M 117.59M
Retained earnings -145.18M -135.47M -121.77M -112.13M -101.38M
Other liab - - - 0.81M 0.83M
Other assets - - - 0.05M 0.06M
Cash 3.14M 3.24M 3.23M 5.22M 10.30M
Cash and equivalents - - - 5.22M 10.30M
Total current liabilities 11.31M 11.31M 8.63M 8.32M 6.48M
Current deferred revenue - - 0.26M 0.50M 0.46M
Net debt 3.34M 0.13M 0.83M -0.52M -4.99M
Short term debt 3.73M - 0.69M 0.73M 0.63M
Short long term debt - 3.38M - - -
Short long term debt total 6.48M - 4.05M 4.70M 5.31M
Other stockholder equity 150.09M - 0.00M -13.26M -16.15M
Property plant equipment - - - 7.73M 8.39M
Total current assets 15.00M 17.08M 19.90M 22.44M 22.74M
Net tangible assets - - - 17.11M 19.14M
Net receivables 7.38M 2.87M 10.15M 7.00M 3.75M
Inventory 4.02M 4.27M 5.38M 7.34M 5.78M
Accounts payable 2.38M 3.28M 2.54M 2.48M 1.30M
Accumulated other comprehensive income - - 4.04M 3.87M 3.08M
Non currrent assets other - - 0.12M - -
Non current assets total 4.71M 5.03M 7.00M 7.86M 8.53M
Capital lease obligations - 3.16M - 4.70M 5.31M
Long term debt total - - - 3.98M 4.68M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -0.10M -0.37M -0.78M -1.11M
Change to liabilities - - - 1.89M 0.67M
Total cashflows from investing activities -0.14M -0.10M -0.37M -0.78M -1.11M
Net borrowings - 3.24M - -0.66M -0.61M
Total cash from financing activities 8.96M 8.71M 4.81M 6.69M -0.61M
Change to operating activities - - - 0.11M 0.32M
Net income -9.88M -13.89M -9.77M -10.75M -17.09M
Change in cash -0.11M 0.01M -2.00M -5.08M -19.83M
Begin period cash flow 3.24M 3.23M 5.22M 10.30M 30.14M
End period cash flow 3.14M 3.24M 3.23M 5.22M 10.30M
Total cash from operating activities -8.92M -8.59M -6.43M -10.99M -18.11M
Issuance of capital stock - 6.37M 5.92M 7.46M -
Depreciation - - 1.55M 1.60M 1.37M
Change to inventory 0.26M -0.33M 1.92M -1.52M -2.89M
Change to account receivables 1.77M 1.12M -1.49M -3.54M -2.59M
Sale purchase of stock - -0.35M -0.40M -0.10M -0.10M
Other cashflows from financing activities -0.72M -0.54M -0.72M -0.66M -0.61M
Change to netincome - - - 1.23M 2.04M
Capital expenditures 0.14M 0.10M 0.37M 0.78M 1.11M
Change in working capital 2.38M 0.78M 0.73M -5.06M -5.48M
Stock based compensation - - 1.07M 1.23M 1.95M
Other non cash items -1.43M -9.37M -0.02M -1.84M -2.39M
Free cash flow -9.07M -8.69M -6.80M -11.77M -19.22M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MX1
Micro-X Ltd		 -
-%		 0.03 - - 1.67 4.86 1.82 -4.61
COH
Cochlear Ltd		 2.26
1.50%		 152.98 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 0.06
4.72%		 1.33 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 0.50
5.88%		 9.00 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.11
2.13%		 5.06 - 9.97 9.59 7.17 6.76 15.37

Profile*

Micro-X Ltd

Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; and imaging chains and custom X-ray imaging solutions, as well as engineering contract services and spare parts. The company has a strategic partnership with Billion Prima to develop and commercialize a baggage and parcel scanner product. Micro-X Limited was incorporated in 2011 and is based in Adelaide, Australia.

A14, 6 MAB Eastern Promenade, Adelaide, SA, Australia, 5042

61 8 7099 3966

https://www.micro-x.com

Name Title Year Born
Mr. Peter Robin Rowland BSc., CEng, FAICD, MBA, MIET MD, CEO & Director NA
Mr. Kingsley Hall BEC CFO & Company Sec. NA
Mr. Alexander Blackburn BEng (Hons), M.B.A. Head of Strategy & Planning and GM of X-Ray Cameras NA
Mr. Anthony Skeats MEng (Hons) Chief Engineer & GM of Computed Tomography NA
Dr. Brian Gonzales GM of Checkpoints & Chief Imaging Scientist NA
Mr. Charlie Hicks Gen. Mang. of Mobile Digital Radiology & Division Head NA
Daniel Pini Gen. Mang. of Core Technology NA
Mr. Dan Ginsburg Bus. & Operations Mang. NA
Ms. Bree Farrugia Gen. Counsel NA
Ms. Lois Newman Head of EMEA Sales- Mobile DR NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…